Evotec SE (Frankfurt Stock Exchange:EVT)(SDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) announced that its translational drug discovery accelerator with Novo Nordisk, LAB eN²,which aims to nurture early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback